Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Gentherm is undergoing a transformational combination with Modine's Performance Technologies business via a Reverse Morris Trust (RMT) transaction valued at $1.0 billion. This deal, expected to close in Q4 2026, will nearly double the company's revenue scale to $2.6 billion pro forma and diversify its end-market exposure beyond cyclical light vehicles into commercial, heavy-duty, and power generation markets. Despite near-term margin pressures from footprint realignment and integration costs, Gentherm's strong market share in automotive thermal management, robust new business awards ($395 million in Q1 2026), and expansion into adjacent markets like home and office furniture (KUKA Home partnership) present a compelling long-term growth profile.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets7 analysts · as of 18 Aug 2026
Low · most bearish analyst$34.00
Mean target$47.71
High · most bullish analyst$59.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario

Integration challenges or delays in closing the Modine transaction pressure the stock. Persistent material and labor cost inflation, combined with prolonged footprint realignment expenses, continue to compress gross margins. A sharper-than-expected downturn in global light vehicle production further limits near-term earnings visibility.

Base CaseCentral scenario

The combination with Modine Performance Technologies closes successfully in Q4 2026, realizing $25 million in annual cost synergies by 2028. Automotive thermal management demand remains resilient, and China domestic OEM launches continue to drive outperformance over the broader light vehicle production market. Restructuring costs subside by late 2026, allowing EBITDA margins to expand toward the pro forma target of 13%.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Transformational RMT combination with Modine Performance Technologies doubling revenue scale and diversifying end-market exposure.
  • Strong commercial momentum with $395 million in automotive new business awards secured in Q1 2026 alone.
  • Market share gains and outperformance over light vehicle production trends, particularly driven by domestic OEM launches in China.
  • Expansion into high-margin adjacent markets, including medical (ThermAffyx FDA submission) and home/office furniture (KUKA Home).
Sign in / Sign up to read more
Key Investment Risks
  • Execution and integration risks associated with the $1.0 billion Modine Performance Technologies transaction.
  • Near-term margin compression from ongoing footprint realignment and restructuring actions through 2026.
  • Cyclical exposure to global light vehicle production volumes and macroeconomic headwinds.
  • Geopolitical and tariff uncertainties affecting global supply chains and material costs.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Failure to close or significant delay in the Modine Performance Technologies combination.
  2. Severe deterioration in gross margins below 22% due to persistent operational inefficiencies or integration friction.
  3. A major drop in automotive new business awards below $1.5 billion annually, indicating loss of market share.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.